Rosier year-end seen for Indian pharma thanks to faster US approvals.
IT, pharma and FMCG stocks are the top performers in 2013.
Asian shares ended higher following a relief rally in global equities after centrist candidate Emmanuel Macron won the first round of the French presidential election.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.
Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation
Gaurav Garg, Head of Research, CapitalVia answers readers' stock market queries
Telangana chief minister K Chandrasekhar Rao on Wednesday announced the establishment of a massive industrial park dedicated to pharmaceutical manufacturing activities.
The market breadth, indicating the overall health of the market, was positive
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Drugs under exemption make up roughly 95 per cent of the antiretrovirals used by India's AIDS patients
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
With sales of over Rs 12,240 crore in nine months of the current financial year, it is ahead of Rs 11,580 crore recorded by Lupin but behind Sun Pharma, which reported Rs 19,350 crore sales.
Quite a few large- and mid-cap stocks are yet to recover from the note ban, pharma, banking and rural demand-based industries among laggards.
With a new higher tax regime coming into effect from the new financial year, top corporates and wealthy investors are in a rush to restructure their shareholding.
Top companies added employees at 3% CAGR from 2003-04 to 2013-14, while revenues grew at 18%.
After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set out to bring the house in order.
The S&P BSE Midcap and the S&P BSE Smallcap indices under-performed to lose 0.8% and 1.6%
Covering-up of short positions ahead of Thursday's expiry of August series in the derivatives segment gave equities a slight push
The S&P BSE Sensex ended the session at 25,342, up 3 points while the Nifty50 closed at 7,738 points.
Mixed global cues and decline in crude oil prices further dent the sentiments.
The country had the third-largest number of people living with disease.
Sun Pharma was by far the biggest gainer in the Sensex pack, surging 8.13 per cent, followed by Dr Reddy's at 4.92 per cent.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
n the broader market, both the BSE Midcap and Smallcap indices, were up 1.2% and 0.7% each.
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
Broader markers outperformed their larger peers.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
After touching a fresh all-time low against the US dollar on Thursday, the rupee jumped 27 paise to end at 68.46.
With global markets pushing ahead, enthused by strengthening US jobs market, and also due to prospects of European rate hike, Indian markets also continued the march ahead.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Life in Telangana is likely to come to a standstill on Tuesday, thanks to the state government's Intensive Household Survey. Not just the state-owned public transport buses, even private vehicles, will remain off the roads.
Gaurav Garg, Head of Research, CapitalVia answers readers' stock market queries.
Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine broader markets.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Audit firms such as KPMG believe zero complaints may be an indicator of the lack of requisite mechanism to allow for such reporting
Broader markets outperformed with BSE Midcap and BSE Smallcap adding 0.23% and 0.45%, respectively
The 30-share Sensex ended down 32 points at 28,851 and the 50-share Nifty closed 12 points lower at 8,712.
FPIs sold shares worth a net Rs 1236.95 crore on Friday.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances